Detalhe da pesquisa
1.
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022.
Ann Oncol
; 34(1): 48-60, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36182023
2.
Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors.
Br J Dermatol
; 185(2): 263-271, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33393076
3.
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study.
Br J Dermatol
; 182(6): 1369-1378, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31545507
4.
Harnessing autophagy to overcome mitogen-activated protein kinase kinase inhibitor-induced resistance in metastatic melanoma.
Br J Dermatol
; 180(2): 346-356, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30339727
5.
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study.
J Eur Acad Dermatol Venereol
; 32(3): 372-381, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-28846163
6.
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors.
Ann Oncol
; 27(12): 2268-2274, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27733373
7.
A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors.
Invest New Drugs
; 34(3): 329-37, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27039386
8.
The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
Br J Dermatol
; 175(6): 1210-1220, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27167239
9.
Policy Transfer Among Regional-Level Organizations: Insights from Source Water Protection in Ontario.
Environ Manage
; 58(1): 31-47, 2016 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-27094441
10.
Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma.
Ann Oncol
; 26(10): 2173-9, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26202595
11.
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma.
Ann Oncol
; 25(5): 968-74, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24567366
12.
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database.
Ann Oncol
; 25(6): 1222-8, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24608201
13.
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.
Br J Cancer
; 108(8): 1634-40, 2013 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-23538388
14.
Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma.
Br J Cancer
; 109(6): 1451-9, 2013 Sep 17.
Artigo
Inglês
| MEDLINE | ID: mdl-23989947
15.
Prevalence of mutations in common tumour types in Northern England and comparable utility of national and international Trial Finders.
J Cancer Res Clin Oncol
; 149(18): 16355-16363, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37702806
16.
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies.
Ann Oncol
; 23(5): 1307-1313, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22015452
17.
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging.
Eur Radiol
; 22(7): 1451-64, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22562143
18.
CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial.
ESMO Open
; 7(6): 100594, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36327756
19.
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.
Nat Commun
; 13(1): 3246, 2022 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35688802
20.
A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours.
Br J Cancer
; 104(4): 593-8, 2011 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21285987